Correction to: Protective Effects of Chinese Herbal Medicine Rhizoma drynariae in Rats After Traumatic Brain Injury and Identification of Active Compound (Molecular Neurobiology, (2016), 53, 7, (4809-4820), 10.1007/s12035-015-9385-x);Protective Effects of Chinese Herbal Medicine Rhizoma drynariae in Rats After Traumatic Brain Injury and Identification of Active Compound

Molecular Neurobiology

Volumn 53, Issue 7, 2016, Pages 4809-4820

  Wang, Wenzhu ^a,b   Li, Haigang ^a   Yu, Jintao ^a   Hong, Michael ^b   Zhou, Jing ^a   Zhu, Lin ^a   Wang, Yang ^a   Luo, Min ^a   Xia, Zian ^a   Yang, Zeng Jin ^b   Tang, Tao ^a   Ren, Ping ^a   Huang, Xi ^a,c   Wang, Jian ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Microglia; Rhizoma drynariae; Traumatic brain injury; UPLC

Indexed keywords

ANTIINFLAMMATORY AGENT; ERIODICTYOL; INTERLEUKIN 10; INTERLEUKIN 6; NEUROPROTECTIVE AGENT; PLANT EXTRACT; RHIZOMA DRYNARIAE EXTRACT; UNCLASSIFIED DRUG; FLAVANONE DERIVATIVE; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHINESE MEDICINE; COGNITION; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG MECHANISM; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MALE; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; POLYPODIACEAE; PROTEIN BLOOD LEVEL; RAT; RHIZOMA DRYNARIAE; TRAUMATIC BRAIN INJURY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; CHEMISTRY; DRUG EFFECTS; ESCAPE BEHAVIOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MAZE TEST; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; BRAIN INJURIES, TRAUMATIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; ESCAPE REACTION; FLAVANONES; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; POLYPODIACEAE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84940706026     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-022-03155-0     Document Type: Erratum

References (48)

1. Thal SC, Neuhaus W (2014) The blood–brain barrier as a target in traumatic brain injury treatment. Arch Med Res 45(8):698–710. doi:10.1016/j.arcmed.2014.11.006
2. Scrimgeour AG, Condlin ML (2014) Nutritional treatment for traumatic brain injury. J Neurotrauma 31(11):989–999. doi:10.1089/neu.2013.3234
3. Warner N, Eggenberger E (2010) Traumatic optic neuropathy: a review of the current literature. Curr Opin Ophthalmol 21(6):459–462. doi:10.1097/ICU.0b013e32833f00c9
4. Taylor AE, Fuller CW, Molloy MG (2011) Injury surveillance during the 2010 IRB Women’s Rugby World Cup. Br J Sports Med 45(15):1243–1245. doi:10.1136/bjsports-2011-090024
5. Andelic N, Sigurdardottir S, Brunborg C, Roe C (2008) Incidence of hospital-treated traumatic brain injury in the Oslo population. Neuroepidemiology 30(2):120–128. doi:10.1159/000120025
6. Stein DG, Geddes RI, Sribnick EA (2015) Recent developments in clinical trials for the treatment of traumatic brain injury. Handb Clin Neurol 127:433–451. doi:10.1016/B978-0-444-52892-6.00028-3
7. McConeghy KW, Hatton J, Hughes L, Cook AM (2012) A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs 26(7):613–636. doi:10.2165/11634020-000000000-00000
8. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF et al (2014) Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 371(26):2457–2466. doi:10.1056/NEJMoa1404304
9. Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N et al (2014) A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med 371(26):2467–2476. doi:10.1056/NEJMoa1411090
10. Wang Y, Fan X, Qu H, Gao X, Cheng Y (2012) Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr Top Med Chem 12(12):1356–1362
11. Ma HD, Deng YR, Tian Z, Lian ZX (2013) Traditional Chinese medicine and immune regulation. Clin Rev Allergy Immunol 44(3):229–241. doi:10.1007/s12016-012-8332-0
12. An HJ, Lee GG, Lee KT (2012) Drynariae rhizoma increases immune response in mice. Nat Prod Commun 7(7):905–908
13. Anuja GI, Latha PG, Suja SR, Shyamal S, Shine VJ, Sini S, Pradeep S, Shikha P et al (2010) Anti-inflammatory and analgesic properties of Drynaria quercifolia (L.) J. Smith. J Ethnopharmacol 132(2):456–460. doi:10.1016/j.jep.2010.08.038
14. Wang WZ, Pan YZ, Wei JB, Huang LP, Huang X, Li K (2012) The effects of rhizoma drynariae on interleukin-2 and T-lymphocyte levels in rats after severe head injury. J Ethnopharmacol 142(1):300–304
15. Chen Y, Lomnitski L, Michaelson DM, Shohami E (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80(4):1255–1262
16. Wang J, Liu X, Lu H, Jiang C, Cui X, Yu L, Fu X, Li Q et al (2015) CXCR4(+)CD45(−) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice. Brain Behav Immun 45:98–108. doi:10.1016/j.bbi.2014.12.015
17. Wang J, Yu L, Jiang C, Fu X, Liu X, Wang M, Ou C, Cui X et al (2015) Cerebral ischemia increases bone marrow CD4 + CD25 + FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun 43:172–183. doi:10.1016/j.bbi.2014.07.022
18. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, Kubes P (1998) Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101(11):2497–2505
19. Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, Liu L, Wang J (2014) Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behav Brain Res 265:171–180. doi:10.1016/j.bbr.2014.02.033
20. Fogaca MV, Sonego AB, Rioli V, Gozzo FC, Dale CS, Ferro ES, Guimaraes FS (2015) Anxiogenic-like effects induced by hemopressin in rats. Pharmacol Biochem Behav 129:7–13. doi:10.1016/j.pbb.2014.11.013
21. Zhu W, Gao Y, Chang CF, Wan JR, Zhu SS, Wang J (2014) Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 9(5):e97423. doi:10.1371/journal.pone.0097423
22. Xie Y, Huang X, Hu SY, Qiu XJ, Zhang YJ, Ren P, Wang Y, Ji H et al (2013) Meranzin hydrate exhibits anti-depressive and prokinetic-like effects through regulation of the shared alpha2-adrenoceptor in the brain-gut axis of rats in the forced swimming test. Neuropharmacology 67:318–325. doi:10.1016/j.neuropharm.2012.10.003
23. Wu H, Wu T, Xu X, Wang J, Wang J (2011) Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 31(5):1243–1250
24. Wu H, Wu T, Li M, Wang J (2012) Efficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury. Neurobiol Dis 45(1):388–394
25. Wang J, Fields J, Zhao C, Langer J, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S et al (2007) Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med 43(3):408–414
26. Wu H, Wu T, Hua W, Dong X, Gao Y, Zhao X, Chen W, Cao W et al (2015) PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice. Neurobiol Aging 36(3):1439–1450. doi:10.1016/j.neurobiolaging.2014.12.029
27. Zhao X, Wu T, Chang CF, Wu H, Han X, Li Q, Gao Y, Li Q et al (2015) Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice. Brain Behav Immun 46:293–310. doi:10.1016/j.bbi.2015.02.011
28. Wu T, Wu H, Wang J, Wang J (2011) Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain. J Neuroinflammation 8:22
29. Qiu XJ, Huang X, Chen ZQ, Ren P, Huang W, Qin F, Hu SH, Huang J et al (2011) Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of chaihu-shugan-San to patients with functional dyspepsia. J Ethnopharmacol 137(1):205–213. doi:10.1016/j.jep.2011.05.009
30. Wang Y, Huang X, Liang QH, Fan R, Qin F, Guo Y, Yan KP, Liu W et al (2012) A strategy for detecting absorbed bioactive compounds for quality control in the water extract of rhubarb by ultra performance liquid chromatography with photodiode array detector. Chin J Integr Med 18(9):690–698. doi:10.1007/s11655-012-1053-7
31. Huang W, Xiong ZH, Huang X, Chen X, Liu WP, Wang Y, Ren P (2012) Simultaneous UPLC analysis of three major flavonoids in granule decoctions of Fructus aurantii-type formulae. Pharmazie 67(7):586–589
32. Mahmood A, Lu D, Wang L, Chopp M (2002) Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 19(12):1609–1617. doi:10.1089/089771502762300265
33. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14(3):149–167
34. Zhang YJ, Huang X, Wang Y, Xie Y, Qiu XJ, Ren P, Gao LC, Zhou HH et al (2011) Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology. Brain Res Bull 86(3–4):222–228. doi:10.1016/j.brainresbull.2011.07.002
35. Werner C, Engelhard K (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99(1):4–9. doi:10.1093/bja/aem131
36. Malkesman O, Tucker LB, Ozl J, McCabe JT (2013) Traumatic brain injury—modeling neuropsychiatric symptoms in rodents. Front Neurol 4:157. doi:10.3389/fneur.2013.00157
37. Wang HC, Yang TM, Lin YJ, Chen WF, Ho JT, Lin YT, Kwan AL, Lu CH (2014) Serial serum leukocyte apoptosis levels as predictors of outcome in acute traumatic brain injury. Biomed Res Int 2014:720870. doi:10.1155/2014/720870
38. Schwulst SJ, Trahanas DM, Saber R, Perlman H (2013) Traumatic brain injury-induced alterations in peripheral immunity. J Trauma Acute Care Surg 75(5):780–788. doi:10.1097/TA.0b013e318299616a
39. Vermeij JD, Aslami H, Fluiter K, Roelofs JJ, van den Bergh WM, Juffermans NP, Schultz MJ, Van der Sluijs K et al (2013) Traumatic brain injury in rats induces lung injury and systemic immune suppression. J Neurotrauma 30(24):2073–2079. doi:10.1089/neu.2013.3060
40. Li M, Lin YP, Chen JL, Li H, Jiang RC, Zhang JN (2015) Role of regulatory T cell in clinical outcome of traumatic brain injury. Chin Med J 128(8):1072–1078. doi:10.4103/0366-6999.155094
41. Zhang B, West EJ, Van KC, Gurkoff GG, Zhou J, Zhang XM, Kozikowski AP, Lyeth BG (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 1226:181–191. doi:10.1016/j.brainres.2008.05.085
42. Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, Clifton GL, Dash PK (2010) Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 7:19. doi:10.1186/1742-2094-7-19
43. Arand M, Melzner H, Kinzl L, Bruckner UB, Gebhard F (2001) Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbeck’s Arch Surg 386(4):241–248
44. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(5):506–512
45. Shang Z, Zhao Q, Tian J, Yang L, Yang M, Shi G (2010) Chemical constituents from rhizomes of Drynaria fortunei. Pract Pharm Clin Rem 13(4):262–277
46. Gao Y, Wang X, Wang N, Yao X (2008) Chemical constituents from Drynaria fortunei. Chin J Med Chem 8(4):284–287
47. Jing X, Ren D, Wei X, Shi H, Zhang X, Perez RG, Lou H, Lou H (2013) Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury. Toxicol Appl Pharmacol 273(3):672–679
48. Lou H, Jing X, Ren D, Wei X, Zhang X (2012) Eriodictyol protects against H(2)O(2)-induced neuron-like PC12 cell death through activation of Nrf2/ARE signaling pathway. Neurochem Int 61(2):251–257. doi:10.1016/j.neuint.2012.05.013